200 participants
Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-11-14
- Start Date:
- 2025-04-14
- Completion:
- 2027-12-31
Conditions
- Overweight or Obesity
- Atrial Fibrillation
Interventions
- DRUG
No Results Yet